Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

50.05
+1.923.99%
Pre-market: 49.80-0.2500-0.50%08:09 EDT
Volume:3.00M
Turnover:150.32M
Market Cap:101.24B
PE:16.01
High:50.30
Open:50.29
Low:49.61
Close:48.13
52wk High:61.70
52wk Low:39.29
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.23
T/O Rate:0.15%
Dividend:1.83
Dividend Rate:3.66%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.26
PE(LYR):13.40

Loading ...

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 25

GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch

TIPRANKS
·
Jun 25

GSK Unit Launches Tender Offer for Nuvalent Acquisition

MT Newswires Live
·
Jun 25

GSK Discloses Executive Notional ADS Acquisition by U.S. President

TIPRANKS
·
Jun 24

GSK launches $124-per-share tender offer to acquire oncology developer Nuvalent

TIPRANKS
·
Jun 24

GSK Climbs Tuesday, Outperforms Market

Dow Jones
·
Jun 24

GSK board members boost holdings with coordinated share purchases

TIPRANKS
·
Jun 23

GSK's Nuvalent Deal Could Be Rare Case of Profitable Oncology Acquisition -- Market Talk

Dow Jones
·
Jun 23

GSK Expands Treasury Stock Position with June Share Buybacks

TIPRANKS
·
Jun 22

GSK Targets Relapsed B-Cell Lymphoma With New Early-Stage Trial

TIPRANKS
·
Jun 19

GSK’s ZEAL-1L Lung Cancer Trial Delivers Mixed Readout With Limited Upside for Niraparib

TIPRANKS
·
Jun 19

GSK Slips Thursday, Underperforms Market

Dow Jones
·
Jun 19

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

GlobeNewswire
·
Jun 18

GSK, Spero Therapeutics Get FDA Approval for Utebzi in Complicated Urinary Tract Infections

MT Newswires Live
·
Jun 18

GSK, Spero Therapeutics announce FDA approval of Utebzi

TIPRANKS
·
Jun 17

GSK wins first US approval for oral carbapenem to treat complicated UTIs

TIPRANKS
·
Jun 17

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 17

Sector Update: Healthcare Stocks Advance in Afternoon Trading

MT Newswires Live
·
Jun 17

GSK Expands Share Buyback, Lifts Treasury Holding to 6.64% of Voting Rights

TIPRANKS
·
Jun 15

GSK Opens New Front in Malaria Prevention With First-in-Human Antibody Trial

TIPRANKS
·
Jun 13